In a filing after the close, Raptor Pharma (NASDAQ: RPTP) disclosed it may sell up to $246.2 million in mixed ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE